Tag: Phase III
Phase III trials show Baxdrostat lowers systolic BP in resistant hypertension
In the Phase III BaxHTN study, baxdrostat 2 mg achieved a placebo-adjusted reduction in seated systolic blood pressure of 9.8 mmHg at 12 weeks, meeting the primary endpoint
Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion
The projected sales of brensocatib may further reflect the great significance and impact of its potential approval on the bronchiectasis market
Sputnik V vaccine authorized in India
India has become the 60th country to approve the Russian vaccine, Sputnik V, one of only three vaccines registered so far in the country.........................
Russia’s Sputnik V vaccine shows 95% efficacy after 42 days, one...
Currently, 40,000 volunteers are taking part in Phase III double-blind, randomized, placebo-controlled clinical post-registration study of the Sputnik V vaccine in Russia. The vaccine will be available in the lyophilized (dry) which is stored at a temperature of +2 to +8 degrees celsius...................
Allogeneic stem cell therapy for peripheral artery disease raises hopes globally
Encouraging Phase II results were released in June 2018 for PLX-PAD, a placenta-based allogeneic stem cell therapy given intramuscularly, targeting peripheral artery disease (PAD)........................